News & Updates

AmyGo Solutions is proud to announce the receipt of our second SBIR award through the National Institutes of Health. This Phase I grant will support the continued development of our proprietary blood test for transthyretin amyloidosis, a fatal and underdiagnosed disease that damages the heart and nerves, affecting hundreds of thousands of Americans. This award would not have been possible without the incredible support of Alyssa Becker, PhD, and Eva Garland Consulting, LLC, w

AmyGo Solutions has been named a 2026 Rising Star by BioNTX, recognizing our work advancing early detection for systemic amyloidosis. The Rising Stars program highlights a group of innovative Texas companies developing new ideas, technologies, and solutions across life sciences and healthcare. As part of the recognition, AmyGo will take the stage at the iC³ Life Science & Healthcare Innovation Summit, held September 24-25, 2026, at the Loews Arlington Hotel & Convention Cente